業績

ページタイトル画像

英文業績 2016-2020年

  • 2016年

2016年 総説5件 原書・短報60件

総説

  1. Kuwabara S, Misawa S. Future treatment for Guillain–Barre syndrome. Clin Exp Neuroimmunol. 2016;7(4):320-323.
  2. Shahrizaila N, Sobue G, Kuwabara S, Kim SH, Birks C, Fan DS, Bae JS, Hu CJ, Gourie-Devi M, Noto Y, Shibuya K, Goh KJ, Kaji R, Tsai CP, Cui L, Talman P, Henderson RD, Vucic S, Kiernan MC. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J Neurol Neurosurg Psychiatry. 2017 ;88(4):283.
  3. Noto Y, Shibuya K, Vucic S, Kiernan MC. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis. Expert Rev Neurother. 2016;16(10):1147-54.
  4. Sekiyama K, Takamatsu Y, Koike W, Waragai M, Takenouchi T, Sugama S, Hashimoto M. Insight into the Dissociation of Behavior from Histology in Synucleinopathies and in Related Neurodegenerative Diseases. J Alzheimers Dis. 2016 ;52(3):831-41.
  5. Takamatsu Y, Koike W, Takenouchi T, Sugama S, Wei J, Waragai M, Sekiyama K, Makoto H. Protection against neurodegenerative disease on Earth and in space. npj Microgravity 2016;2:16013.

原著・短報

  1. Aiba Y, Sakakibara R, Abe F, Higuchi T, Tokuyama W, Hiruta N, Tateno F, Tsuyusaki Y, Kishi M, Tateno H, Ogata T. Neuronal intranuclear inclusion disease with leukoencephalopathy and light motor-sensory and autonomic neuropathy diagnosed by skin biopsy. J Neurol Sci. 2016;368:263-5.
  2. Aiba Y, Iwakawa M, Sakakibara R, Tsuyusaki Y, Tateno F, Kishi M, Tateno H, Ogata T. Myasthenia Gravis Manifesting As Head Drop in an Elderly Adult with Parkinson's Disease. J Am Geriatr Soc. 2016 ;64(10):e120-e122.
  3. Akaishi T, Suzuki Y, Imai T, Tsuda E, Minami N, Nagane Y, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Murai H, Aoki M, Utsugisawa K. Response to treatment of myasthenia gravis according to clinical subtype. BMC Neurol. 2016;16:225.
  4. Akiba R, Yokouchi H, Mori M, Oshitari T, Baba T, Sawai S, Kuwabara S, Yamamoto S. Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD). PLoS One. 2016;11(12):e0167473.
  5. Aotsuka Y, Uzawa A, Nishimura K, Kojima K, Yamaguchi M, Makino T, Nakamichi K, Saijo M, Kuwabara S. Progressive Multifocal Leukoencephalopathy Localized in the Cerebellum and Brainstem Associated with Idiopathic CD4+ T Lymphocytopenia. Intern Med. 2016;55(12):1645-7.
  6. Araki N, Misawa S, Shibuya K, Ota S, Oide T, Kawano A, Beppu M, Nakatani Y and Kuwabara S. POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification. Orphanet J Rare Dis. 2016;11:35.
  7. Gulimire Abulaiti, Sawai S, Satoh M, Yamada M, Yaguchi M, Sogawa K, Beppu M, Kazami T, Kado S, Matsushita K, Tsukamoto A, Inomata T, Arai K, Kodera Y, Kuwabara S and Nomura F. Proteome Analysis of the Cerebellum Tissue in Chronically Alcohol-Fed Rats. J Alcohol Drug Depend. 2016;4(5):1000249.
  8. Hayano Y, Takasu K, Koyama Y, Yamada M, Ogawa K, Minami K, Asaki T, Kitada K, Kuwabara S, Yamashita T. Dorsal horn interneuron-derived Netrin-4 contributes to spinal sensitization in chronic pain via Unc5B. J Exp Med. 2016 Dec 12;213(13):2949-2966.
  9. Hiraga A, Koide K, Aotsuka Y, Kuwabara S. Reversible cerebral vasoconstriction syndrome with transient splenial lesion after delivery. Intern Med. 2016;55(22):3357-3359.
  10. Kaminski HJ, Himuro K, Alshaikh J, Gong B, Cheng G, Kusner LL. Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats. Front Physiol. 2016;7:524.
  11. Iwai Y, Shibuya K, Misawa S, Sekiguchi Y, Watanabe K, Amino H, Kuwabara S. Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis. PLoS One 2016;11(7):e0158596.
  12. Kanai T, Uzawa A, Kawaguchi N, Sakamaki T, Yoshiyama Y, Himuro K, Oda F, Kuwabara S. HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients. J Neurol Sci. 2016;363:116-8.
  13. Koga S, Dickson DW, Bieniek KF. Chronic Traumatic Encephalopathy Pathology in Multiple System Atrophy. J Neuropathol Exp Neurol. 2016;75(10):963-970.
  14. Koga S, Keith A. Josephs, Ogaki K, Catherine Labbé, Ryan J. Uitti, Neill Graff-Radford, Jay A. van Gerpen, William P. Cheshire, Aoki N, Rosa Rademakers, Zbigniew K. Wszolek, Owen A. Ross, Dennis W. Dickson. Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C. Mov Disord. 2016;31(5):653-62.
  15. Labbé C, Heckman MG, Lorenzo-Betancor O, Murray ME, Ogaki K, Soto-Ortolaza AI, Walton RL, Fujioka S, Koga S, Uitti RJ, van Gerpen JA, Petersen RC, Graff-Radford NR, Younkin SG, Boeve BF, Cheshire WP Jr, Low PA, Sandroni P, Coon EA, Singer W, Wszolek ZK, Dickson DW, Ross OA. MAPT haplotype diversity in multiple system atrophy. Parkinsonism Relat Disord. 2016;30:40-5.
  16. Masuda H, Mori M, Hirano S, Uzawa A, Uchida T, Ohtani R, Takahashi N, Kuwabara S. Impaired cognitive function and grey matter volume in multiple sclerosis relative to neuromyelitis optica spectrum disorder. Multiple sclerosi journal. 2016;22(S3):767-768.
  17. Masuda H, Mori M, Uzawa A, Muto M, Uchida T, Otani R, Akiba R, Yokouchi H, Yamamoto S, Kuwabara S. Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis. J Neurol Sci. 2016;367:375-9.
  18. Masuda H. Congress report of the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Barcelona. Clin Exp Neuroimmunol. 2016;(7)1:91-93.
  19. Masuda H, Mori M, Araki N, Kuwabara S. Bilateral Foot Acrocyanosis in an Interferon-β-treated MS Patient. Intern Med. 2016;55(3):319.
  20. Masuda H, Mori M, Uzawa A, Muto M, Uchida T, Kuwabara S. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica. Eur J Neurol. 2016;23(2):276-81.
  21. Misawa S, Sato Y, Katayama K, Nagashima K, Aoyagi R, Sekiguchi Y, Sobue G, Koike H, Yabe I, Sasaki H, Watanabe O, Takashima H, Nishizawa M, Kawachi I, Kusunoki S, Mitsui Y, Kikuchi S, Nakashima I, Ikeda S, Kohara N, Kanda T, Kira J, Hanaoka H, Kuwabara S, Japanese POEMS Syndrome for Thalidomide (J-POST) Trial Study Group. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2016;15(11):1129-37.
  22. Muto T, Ohwada C, Sawai S, Beppu M, Tsukamoto S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Sogawa K, Misawa S, Shimizu N, Iseki T, Nomura F, Kuwabara S, Nakaseko C. Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis. Transfus Apher Sci. 2016;54(2):276-81.
  23. Nakamura H, Sakakibara R, Sugiyama M, Tateno F, Yano M, Takahashi O, Kishi M, Tsuyusaki Y, Tateno H, Aiba Y, Ogata T, Yamamoto T, Yamanishi T, Uchiyama T, Suzuki H, Tateno A, Suzuki Y. Neurologic diseases that cause female urinary retention. Bladder. 2016; 3: e20
  24. Nakamura R, Sone J, Atsuta N, Tohnai G, Watanabe H, Yokoi D, Nakatochi M, Watanabe H, Ito M, Senda J, Katsuno M, Tanaka F, Li Y, Izumi Y, Morita M, Taniguchi A, Kano O, Oda M, Kuwabara S, Abe K, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Aoki M, Hattori N, Tsuji S, Nakashima K, Kaji R, Sobue G; Japanese Consortium for Amyotrophic Lateral Sclerosis Research (JaCALS). Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging. 2016;39:219.e1-8.
  25. Nishimura K, Koga M, Minematsu K, Jun C. Takahashi, Nagatsuka K, Kobayashi J, Toyoda K. Intracerebral hemorrhage in patients after heart valve replacement. J Neurol Sci. 2016;363:195-9.
  26. Notturno F, Kokubun N, Sekiguki Y, Nagashima T, De Lauretis A, Yuki N, Kuwabara S, Uncini A. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes. J Neurol Sci. 2016;365:132-6.
  27. Nozaki H, Kato T, Nihonmatsu M, Saito Y, Mizuta I, Noda T, Koike R, Miyazaki K, Kaito M, Ito S, Makino M, Koyama A, Shiga A, Uemura M, Sekine Y, Murakami A, Moritani S, Hara K, Yokoseki A, Kuwano R, Endo N, Momotsu T, Yoshida M, Nishizawa M, Mizuno T, and Onodera O. Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology. 2016;86(21):1964-74.
  28. Ogaki K, Koga S, Aoki N, Lin W, Suzuki K, Ross OA, Dickson DW. Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review. Neuropathology. 2016;36(1):64-76.
  29. Ogata T, Sakakibara R, Tateno F, Tsuyusaki Y, Tateno H, Aiba Y, Kishi M, Inaoka T, Terada H, Doi H, Suzuki Y. Mild Cognitive Impairment as the Initial Manifestation of Progressive Supranuclear Palsy. J Am Geriatr Soc. 2016;64(3):683-5.
  30. Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H. Parkinson's Disease Subcomittee, The Neurourology Promotion Committee in The International Continence Society.  A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551-63.
  31. Sakakibara R, Uchida Y, Ishii K, Hashimoto M, Ishikawa M, Kazui H, Yamamoto T, Uchiyama T, Tateno F, Kishi M, Tsuyusaki Y, Aiba Y, Tateno H, Nagao T, Terada H, Inaoka T; Members of SINPHONI (Study of Idiopathic Normal Pressure Hydrocephalus On Neurological Improvement). Bladder recovery relates with increased mid-cingulate perfusion after shunt surgery in idiopathic normal-pressure hydrocephalus: a single-photon emission tomography study. Int Urol Nephrol. 2016;48(2):169-74.
  32. Laitman BM, Asp L, Mariani JN, Zhang J, Liu J, Sawai S, Chapouly C, Horng S, Kramer EG, Mitiku N, Loo H, Burlant N, Pedre X, Hara Y, Nudelman G, Zaslavsky E, Lee YM, Braun DA, Lu QR, Narla G, Raine CS, Friedman SL, Casaccia P, John GR. The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination. PLoS Biol. 2016;14(5):e1002467.
  33. Ishiura H, Takahashi Y, Hayashi T, Saito K, Furuya H, Watanabe M, Murata M, Suzuki M, Sugiura A, Sawai S, Shibuya K, Ueda N, Ichikawa Y, Kanazawa I, Goto J, Tsuji S. Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses. J Hum Genet. 2016;61(4):363-4.
  34. Ishige T, Nishimura M, Satoh M, Fujimoto M, Fukuyo M, Semba T, Kado S, Tsuchida S, Sawai S, Matsushita K, Togawa A, Matsubara H, Kaneda A, Nomura F. Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation. Scientific reports. 2016;6:21681.
  35. Drake MJ, Apostolidis A, Cocci A, Emmanuel A, Gajewski JB, Harrison SC, Heesakkers JP, Lemack GE, Madersbacher H, Panicker JN, Radziszewski P, Sakakibara R, Wyndaele JJ. Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence 2013. Neurourol Urodyn. 2016;35(6):657-65.
  36. Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H; Parkinson's Disease Subcomittee, The Neurourology Promotion Committee in The International Continence Society. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551-63.
  37. Sekiguchi Y, Mori M, Misawa S, Sawai S, Yuki N, Beppu M, Kuwabara S. How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis? Eur J Neurol. 2016 ;23(6):1058-63.
  38. Shibuya K, Misawa S, Kimura H, Noto Y, Sekiguchi Y, Iwai Y, Shimizu T, Mizuno T, Nakagawa M, Kuwabara S. Increased motor axonal persistent sodium currents predict rapid functional declines in amyotrophic lateral sclerosis. Neurology and Clinical Neuroscience. 2016;4(3):108-11.
  39. Shibuya K, Susanna B. Park, Nimeshan Geevasinga, Parvathi Menon, James Howells, Neil G. Simon, William Huynh, Noto Y, Jürgen Götz, Jillian J Kril, Lars M Ittner, John Hodges, Glenda Halliday, Steve Vucic, and Matthew C. Kiernan. Motor cortical function determines prognosis in sporadic ALS. Neurology. 2016;87(5):513-20
  40. Shibuya K, Susanna B. Parka, Nimeshan Geevasingab, William Huynha, Neil G. Simona, Parvathi Menonb, James Howellsa, Steve Vucicb, Matthew C. Kiernana. Clin Neurophysiol. 2016;127(6):2355-61.
  41. Shimada H, Kitamura S, Shinotoh H, Endo H, Niwa F, Hirano S, Kimura Y, Zhang M R, Kuwabara S, Suhara T ,Higuchi M. Association between Abeta and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3-PET study. Alzheimers Dement (Amst). 2016;6:11-20.
  42. Sugiyama A, Kobayashi M, Moriishi H, Tanaka H, Mitsuyoshi R, Matsunaga T, Kuwabara S. Pneumocephalus associated with Pott’s puffy tumor. J Neurol Sci. 2016;362:196-7.
  43. Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, Kuroda S, Yamada K, Miyamoto S; JAM Trial Investigators. Significance of the Hemorrhagic Site for Recurrent Bleeding: Prespecified Analysis in the Japan Adult Moyamoya Trial. Stroke. 2016;47(1):37-43.
  44. Tateno F, Sakakibara R, Aiba Y, Tsuyusaki Y, Kishi M, Tateno H, Ogata T. Stercoral Ulcer and Colonic Perforation in an Individual with Parkinson's Disease with Constipation. J Am Geriatr Soc. 2016 ;64(10):e118-e120.
  45. Tudor KI, Sakakibara R, Panicker JN. Neurogenic lower urinary tract dysfunction: evaluation and management. J Neurol. 2016;263(12):2555-2564.
  46. Tsuyusaki Y, Sakakibara R, Tateno F, Aiba Y, Kishi M, Tateno H, Ogata T, Inaoka T, Terada H, Suzuki Y. Multiple system atrophy presenting initially as spastic paraparesis. J Neurol Sci. 2016;360:176-8.
  47. Tsuyusaki Y, Sakakibara R, Ogata T, Tateno F, Kishi M, Tateno H, Aiba Y. Depth perception disorder after left ventral occipital lobe infarction. Neurocase. 2016;22(2):248-50.
  48. Uzawa A,Kanai T, Kawaguchi N, Oda F, Ozawa Y, Himuro K, Kuwabara, S. Relationship between damage-associated molecular pattern and cytokine levels in myasthenia gravis. Clin Exp Neuroimmunol. 2016;7(4):357-60.
  49. Uzawa A, Mori M, Uchida T, Masuda H, Ohtani R, Kuwabara S. Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria. Mult Scler. 2016;22(10):1371-5.
  50. Uzawa A, Kanai T, Kawaguchi N, Oda F, Himuro K, Kuwabara S. Changes in inflammatory cytokine networks in myasthenia gravis. Sci Rep. 2016;6:25886.
  51. Uzawa A, Mori M, Uchida T, Masuda H, Ohtani R, Kuwabara S. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis. Clin Chim Acta. 2016;453:131-3.
  52. Watanabe H, Atsuta N, Hirakawa A, Nakamura R, Nakatochi M, Ishigaki S, Iida A, Ikegawa S, Kubo M, Yokoi D, Watanabe H, Ito M, Katsuno M, Izumi Y, Morita M, Kanai K, Taniguchi A, Aiba I, Abe K, Mizoguchi K, Oda M, Kano O, Okamoto K, Kuwabara S, Hasegawa K, Imai T, Kawata A, Aoki M, Tsuji S, Nakashima K, Kaji R, Sobue G. A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J Neurol Neurosurg Psychiatry. 2016;87(8):851-8.
  53. Waragai M, Adame A, Trinh I, Sekiyama K, Takamatsu Y, Une K, Masliah E, Hashimoto M. Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease. J Alzheimers Dis. 2016;52(4):1453-9.
  54. Yamaguchi N, Misawa S, Sato Y, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kohara N, Hirata K, Nishiyama K, Yabe I, Kaida KI, Suzuki N, Nodera H, Tsuji S, Koike H, Kira JI, Hanaoka H, Kusunoki S, Kuwabara S. A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS). JMIR Res Protoc. 2016;5(4):e210.
  55. Yamamoto T, Tateno F, Sakakibara R, Furukawa S, Asahina M, Uchiyama T, Hirano S, Yamanaka Y, Fuse M, Koga Y, Yanagisawa M, Kuwabara S. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders. PLoS One. 2016;11(2):e0149278.
  56. Yamamoto T, Mori M, Uzawa A, Uchiyama T, Sakakibara R, Yanagisawa M, and Kuwabara S. Urinary symptoms and neurological disabilities are differentially correlated between multiple sclerosis and neuromyelitis optica. Clin Exp Neuroimmunol.2016;7(1):52-58.
  57. Yamamoto T, Asahina M, Yamanaka Y, Uchiyama T, Hirano S, Sugiyama A, Sakakibara R, Kuwabara S. Urinary Dysfunctions Are More Severe in the Parkinsonian Phenotype of Multiple System Atrophy. Movement Disorders Clinical Practice 2016;3(3):275-281.
  58. Yano M, Sakakibara R, Tateno F, Takahashi O, Nakamura H, Sugiyama M, Fang-Ching L, Kamijima S, Kamiya N, Suzuki H. Urodynamic findings in patients with Creutzfeldt-Jakob disease: a case report. Int Urol Nephrol. 2016;48(10):1579-83.
  59. Yokoi D, Atsuta N, Watanabe H, Nakamura R, Hirakawa A, Ito M, Watanabe H, Katsuno M, Izumi Y, Morita M, Taniguchi A, Oda M, Abe K, Mizoguchi K, Kano O, Kuwabara S, Kaji R, Sobue G; JaCALS. Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis. J Neurol. 2016;263(6):1129-36.
  60. Yokouchi H, Baba T, Misawa S, Sawai S, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol. 2016;100(7):897-901.